retatrutide glp-1 gip glucagon receptor agonist mechanism triple What GLP‑3 Really Is: Retatrutide Triple‑Receptor Drug Retatrutide 10mg — Triple Receptor

While both peptides share similarities in administration, subtle differences exist

(2003) Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide

doi: 10.1210/er.2006-0007 [DOI] [PubMed] [Google Scholar] 134

While the specific mechanism causing the effects on the gastrointestinal tract are not fully elucidated, studies suggest GLP-1 and its analogues likely exert effects on the vagus nerve and inhibit cholinergic neurotransmission in the gastrointestinal system to prevent movement of the intestine

In the TRIUMPH-1 Phase 3 trial, participants on the highest dose of retatrutide lost an average of 28.3% of their body weight at 80 weeks

Russells viper venom has inspired molecules for autoimmune disease